Joel Lewis, President and CEO: Galectin Therapeutics GALT Buy · Filed 24/04/25

Trade details

Type: Insider buy
Amount: $3,390
Shares · price: 1,000 sh · $3.39 a share
Held after: 2,000 sh
Stock: Galectin Therapeutics GALT
Person: Joel LewisPresident and CEO
Trade date: 24/04/24
Filed: 24/04/25
Days to filing: 1 days

First buy in 1 years

Since the last buy: 1.2 years
Last buy: 23/02/16
Insiders buying this week: 3 insiders
Holding change: +100.0%

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/25~24/05/24

Joel Lewis's recent trades

Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$135K
37,698 sh
$135K
Filed 01/06
Traded 01/06
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$108.4K
27,731 sh
$108.4K
Filed 01/06
Traded 01/05
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$78K
18,571 sh
$78K
Filed 01/06
Traded 01/02
Joel LewisPresident and CEO
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$352.8K
84,000 sh
$352.8K
Filed 01/02
Traded 01/02
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$55.3K
7,829 sh
$55.3K
Filed 25/12/19
Traded 25/12/17